Clinical Research Directory
Browse clinical research sites, groups, and studies.
Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial
Sponsor: University of Sao Paulo
Summary
This clinical trial aims to investigate the short and long-term efficacy of a harm reduction intervention in reducing the use of non-clinical anabolic-androgenic steroids (AAS) in abusive users of AAS. As secondary objectives, the study will investigate the intervention's effect on health parameters (i.e., blood), quality of life, sleep quality, body image, eating behavior, depression, anxiety, fatigue, aggressiveness, cardiovascular parameters, muscle strength, body composition and muscle cross-sectional area outcomes.
Key Details
Gender
All
Age Range
15 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2026-07-01
Completion Date
2027-12-30
Last Updated
2026-05-18
Healthy Volunteers
Yes
Conditions
Interventions
harm reduction intervention in non-clinical anabolic-androgenic steroids users
Participants will receive four structured counseling sessions, each lasting up to 30 minutes. Utilizing a non-judgmental harm reduction framework, these sessions aim to reduce substance abuse and address associated health risks. The intervention is person-centered, tailoring discussions to the user's specific needs and questions regarding their health and the use of non-clinical anabolic-androgenic steroids (AAS).
Locations (1)
Clinical Hospital of the School of Medicine, University of Sao Paulo
São Paulo, São Paulo, Brazil